Sinan Ozkavukcu

Sinan Ozkavukcu

Auto-generated profile, based on publicly available information

Sinan Ozkavukcu

Center for Assisted Reproduction, Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2008 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
SOSinan Ozkavukcu
Sinan Ozkavukcu
EEEsra Erdemli
Esra Erdemli
AIAyca Isik
Ayca Isik
DODerya Oztuna
Derya Oztuna
SKSercin Karahuseyinoglu
Sercin Karahuseyinoglu

16 June 2020 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MSMurat Sonmezer
Murat Sonmezer
SOSinan Ozkavukcu
Sinan Ozkavukcu
YŞYavuz Emre Şükür
Yavuz Emre Şükür
DKDuygu Kankaya
Duygu Kankaya
OAOnder Arslan
Onder Arslan

5 February 2018 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
SOSinan Ozkavukcu
Sinan Ozkavukcu
CCCiler Celik-Ozenci
Ciler Celik-Ozenci
EKEsma Konuk
Esma Konuk
CACem Atabekoglu
Cem Atabekoglu
Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility. Here, with a comprehensive literature review, we report a couple with an infertility history of 9 years and three unsuccessful IVF treatments, where male partner has Kartagener’s Syndrome, a subtype of PCD, displaying recurrent respiratory infections, dextrocardia and total asthenozoospermia. His diagnosis was verified with transmission electron microscopy and genetic mutation screening, revealing total absence of dynein arms in sperm tails and homozygous mutation in the ZMYND10, heterozygous mutations in the ARMC4 and DNAH5 genes. Laser assisted viability assay (LAVA) was performed by shooting the sperm tails during sperm retrieval for microinjection, following detection of pentoxifylline resistant immotile sperm. Live births of healthy triplets, one boy and two monozygotic girls, was achieved after double blastocyst transfer.

4 May 2011 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
SLSanghoon Lee
Sanghoon Lee
SOSinan Ozkavukcu
Sinan Ozkavukcu
EHElke Heytens
Elke Heytens
FMFred Moy
Fred Moy
RARose M. Alappat
Rose M. Alappat
KOKutluk Oktay
Kutluk Oktay
To predict embryo/oocyte cryopreservation cycle (ECC) outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone for fertility preservation based on observed anti-mullerian hormone (AMH) levels and antral follicle counts (AFC).

8 May 2018 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
OAOya Sena Aydos
Oya Sena Aydos
YYYunus Yukselten
Yunus Yukselten
SOSinan Ozkavukcu
Sinan Ozkavukcu
ASAsuman Sunguroglu
Asuman Sunguroglu
KAKaan Aydos
Kaan Aydos
In this study, our aim was to detect protein levels of A Disintegrin and Metalloproteinase with Thrombospondin Motifs 1 and 5 (ADAMTS1 and ADAMTS5) proteases and to examine the effect of in vitro FSH supplementation on protease production in cultured Sertoli cells. The expression of metalloproteases, ADAMTS1, and ADAMTS5 were investigated in Sertoli cell cultures as well as in ejaculate of azoospermic men which then were compared with ejaculates of the fertile control group. A total of 15 azoospermic men, diagnosed as obstructive (OA, n = 5) and nonobstructive (NOA, n = 10) azoospermia were included in the study. ADAMTS1, ADAMTS5 and FSH receptors (FSHR) were found to be expressed 2.56, 2.10, and 2.66-fold less in Sertoli cells of NOA patients, than those of OA (p < 0.05). After rFSH was added onto Sertoli cell cultures of NOA patients, their expression did not increase significantly and did not reach to levels of control group. Evaluation of ejaculates revealed that the expression of ADAMTS1 and ADAMTS5 were insignificantly 1.03 and 1.1-fold higher in OA group (p > 0.05), respectively; however, in the NOA group, their expression were 1.70 and 1.96-fold lower, respectively, when compared with the fertile control group (p < 0.05) which was statistically significant. As a conclusion, the present study has revealed that insufficiency of ADAMTS1 and ADAMTS5 expression in Sertoli cells may have an important role in the etiology of male infertility. As expected due to low FSHR expression, rFSH response is impaired in NOA patients with relatively low ADAMTS expression response; therefore, such patients might hardly benefit from rFSH treatment. Further studies with larger cohorts may reveal ADAMTSs’ potential use as a predictive marker for positive sperm retrieval in azoospermic patients who are scheduled to undergo testicular sperm extraction. Abbreviations: ADAM: A Disintegrin and Metalloproteinase; ADAMTS1 and ADAMTS5: A Disintegrin and Metalloproteinase with 10 Thrombospondin Motifs 1 and 5; ADAMTS: A Disintegrin and Metalloproteinase with Thrombospondin; ABP: androgen binding protein; CAMs: cell adhesion molecules; ECM: extracellular matrix; FSH: follicle stimulating hormone; FSHR: FSH receptors; HRP: horseradish peroxidase; MMP: matrix metalloproteinases; MP: metalloproteinases; NOA: nonobstructive azoospermia; OA: obstructive azoospermia; TIMP-1: tissue inhibitor of metalloproteinase-1

23 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DADileyra Adiguzel
Dileyra Adiguzel
PSPinar Sahin
Pinar Sahin
NKNilay Kuscu
Nilay Kuscu
SOSinan Ozkavukcu
Sinan Ozkavukcu
NBNayce Ilayda Bektas
Nayce Ilayda Bektas
CCCiler Celik-Ozenci
Ciler Celik-Ozenci
Recent studies indicate that FoxO1 has roles in female reproductive system, especially in maternal endometrium. Although various cellular aspects and molecular pathways have been identified, the exact molecular characteristics of embryo implantation are still not completely understood. In this study, we aimed to investigate uterine expression and regulation of FoxO1 during peri-implantation period in mice. Experimental mouse models including, normal pregnancy, pseudopregnancy, artificial decidualization, and delayed implantation and activation were performed. Our results showed that FoxO1 expression was spatiotemporal in mouse endometrial tissue throughout peri-implantation period and its expression was significantly upregulated in luminal and glandular epithelium at the time of implantation. Moreover, on day 5 morning (09:00 AM) of pregnancy, expression of FoxO1 was cytoplasmic in endometrial luminal epithelial cells where embryo homing takes place. With progressing time on day 5 evening (19:00 PM) of pregnancy FoxO1 expression was nuclear in luminal epithelium at implantation site. Pseudopregnancy and artificial decidualization models indicated that FoxO1 expression was regulated by pregnancy hormones. Delayed implantation and activation model indicated that FoxO1 expression at the time of implantation is dependent upon activation status of blastocyst due to E2 induction and uterine sensitivity to implantation. In conclusion, our findings highlight a perspective for FoxO1 expression and regulation in mouse uterus during peri-implantation period indicating that its expression is regulated by implanting embryo and pregnancy hormones.